Trial Profile
The Use of Valsartan for the Management of Blood Pressure in Acute Stroke: Effects on Cerebral Blood Flow.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms BLAST
- 25 May 2016 NCT00627991 and NCT01400256 look like similar trials thus not separated the profile.
- 21 Mar 2008 New trial record.